688068 热景生物
2025/09 - 九个月2024/122023/122022/122021/12

盈利能力分析
净资产收益率 ROE (%)-3.627-5.9290.86330.580121.897
总资产报酬率 ROA (%)-3.335-5.5380.77425.04696.133
投入资产回报率 ROIC (%)-3.573-5.8740.84428.652111.849

边际利润分析
销售毛利率 (%)55.02755.36057.12753.71159.538
营业利润率 (%)-36.066-36.3263.41230.67248.134
息税前利润/营业总收入 (%)-41.366-42.941-5.07429.29048.151
净利润/营业总收入 (%)-35.673-38.3523.05126.01241.019

收益指标分析
经营活动净收益/利润总额(%)99.61953.547-302.162117.095102.716
价值变动净收益/利润总额(%)3.3574.984-157.9721.0150.964
营业外收支净额/利润总额(%)0.3911.216-24.724-1.454-0.101

偿债能力分析
流动比率 (X)5.0655.4794.4673.5173.429
速动比率 (X)4.7705.1253.7373.2153.077
资产负债率 (%)8.6747.5705.75613.99221.154
带息债务/全部投入资本 (%)2.0050.0350.7562.1538.587
股东权益/带息债务 (%)4,863.552287,930.29613,052.2494,497.7711,050.889
股东权益/负债合计 (%)1,054.0141,221.5811,638.419611.307368.803
利息保障倍数 (X)8.0196.9620.650-31.106738.811

营运能力分析
应收账款周转天数 (天)97.15942.15740.6046.7272.139
存货周转天数 (天)156.397174.159223.36745.14231.893